isoxazoles has been researched along with Synovitis in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (50.00) | 29.6817 |
2010's | 3 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Conde, C; García, S; Gómez-Reino, JJ; González, A; Martínez, P; Orosa, B | 1 |
Harman, H; Harman, S; Kaban, N; Tekeoğlu, I | 1 |
Davis, JM; Matteson, EL | 1 |
Nakayamada, S; Ra, C; Saito, K; Sawamukai, N; Tanaka, Y; Yamaoka, K | 1 |
Barg, EC; Breedveld, FC; Emery, P; Farnell, J; Kraan, MC; Reece, RJ; Rosenburg, R; Smeets, TJ; Tak, PP; Veale, DJ | 1 |
Breedveld, FC; Emery, P; Gibbon, WW; Kraan, MC; O'Connor, PJ; Radjenovic, A; Reece, RJ; Ridgway, JP; Tak, PP; Veale, DJ | 1 |
1 review(s) available for isoxazoles and Synovitis
Article | Year |
---|---|
My treatment approach to rheumatoid arthritis.
Topics: Abatacept; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antirheumatic Agents; Arthritis, Rheumatoid; Biological Products; Comorbidity; Diagnosis, Differential; Drug Therapy, Combination; Evidence-Based Medicine; Humans; Immunoconjugates; Isoxazoles; Joints; Leflunomide; Methotrexate; Prednisone; Prognosis; Quality of Life; Randomized Controlled Trials as Topic; Referral and Consultation; Remission Induction; Rituximab; Severity of Illness Index; Sulfasalazine; Synovitis; Time Factors; Treatment Outcome; Tumor Necrosis Factor-alpha | 2012 |
2 trial(s) available for isoxazoles and Synovitis
Article | Year |
---|---|
Modulation of inflammation and metalloproteinase expression in synovial tissue by leflunomide and methotrexate in patients with active rheumatoid arthritis. Findings in a prospective, randomized, double-blind, parallel-design clinical trial in thirty-nine
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Double-Blind Method; Humans; Immunohistochemistry; Isoxazoles; Leflunomide; Metalloendopeptidases; Prospective Studies; Synovial Membrane; Synovitis; Therapeutic Equivalency | 2000 |
Comparative assessment of leflunomide and methotrexate for the treatment of rheumatoid arthritis, by dynamic enhanced magnetic resonance imaging.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Female; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Prospective Studies; Synovitis; Treatment Outcome | 2002 |
3 other study(ies) available for isoxazoles and Synovitis
Article | Year |
---|---|
Lysophosphatidic acid receptor inhibition as a new multipronged treatment for rheumatoid arthritis.
Topics: Animals; Arthritis, Experimental; Arthritis, Rheumatoid; Autoantibodies; Calcification, Physiologic; Cell Differentiation; Disease Models, Animal; Isoxazoles; Mice; Mice, Inbred C57BL; Mice, Inbred NOD; Osteoblasts; Osteoclasts; Propionates; Receptors, Lysophosphatidic Acid; Synovitis | 2014 |
Factors influencing ultrasonographic remission in patients with rheumatoid arthritis.
Topics: Adalimumab; Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Cohort Studies; Delayed Diagnosis; Etanercept; Female; Hand Joints; Humans; Isoxazoles; Leflunomide; Logistic Models; Male; Methotrexate; Middle Aged; Multivariate Analysis; Remission Induction; Rituximab; Severity of Illness Index; Sulfasalazine; Synovitis; Tenosynovitis; Time Factors; Ultrasonography, Doppler | 2015 |
Leflunomide inhibits PDK1/Akt pathway and induces apoptosis of human mast cells.
Topics: Aniline Compounds; Apoptosis; Arthritis, Rheumatoid; Cell Survival; Cells, Cultured; Chronic Disease; Crotonates; Dihydroorotate Dehydrogenase; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Humans; Hydroxybutyrates; Immunosuppressive Agents; Inflammation Mediators; Isoxazoles; Leflunomide; Mast Cells; Nitriles; Oxidoreductases Acting on CH-CH Group Donors; Phosphorylation; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-akt; Pyruvate Dehydrogenase Acetyl-Transferring Kinase; Signal Transduction; Synovial Membrane; Synovitis; Toluidines; Uridine | 2007 |